Growth Outlook Polaris Market Research reports that the cell lysis & disruption market was valued at USD 5.75 billion in 2024, with a 2025 value of USD 6.23 billion and a revenue forecast of USD 13.03 billion by 2034 at a CAGR of 8.5%. Growth reflects increasing demand for cell-based research, rising adoption of recombinant protein production and monoclonal antibody development, and...